Rolling Up Our Sleeves, Part 3: Fighting the Trump Administration with State Constitutions

A fierce feminist resistance is ready to defend women’s rights at the federal level—and creatively expand equality protections in the states. This is the third in a four-part series on the steps activists are taking to fight for our rights amid Trump’s attacks on democracy.

(This is the third in a four-part series on the steps activists are taking to fight for our rights amid Trump administration’s attacks on democracy.)

Loretta Ross on ‘Calling In’: 25 Lessons on Change, Compassion and Cancel Culture

In Calling In: How to Start Making Change with Those You’d Rather Cancel, activist and scholar Loretta Ross challenges us to move beyond cancel culture and embrace a more humane approach to accountability. “A call in is a call out done with love,” she explains, emphasizing that true change requires “creating the conditions for differences of opinion to be heard” rather than relying on shame and ideological rigidity. With truth and history on our side, Ross urges us to build bridges, not burn them, leading a “revolution of moral renewal” that unites rather than divides.

Attacks on Clinics, Abandonment of Justice—And the Feminist Resistance Rising in Response

Trump’s pardon of 23 antiabortion extremists—followed by the Justice Department’s decision to stop prosecuting most FACE Act violations—has emboldened those who seek to terrorize clinic workers and patients. But feminists are fighting back. From lawmakers to grassroots organizers, the movement is rolling up its sleeves to defend reproductive rights and strategize for the battles ahead.

‘Calling In’: Loretta Ross’ New Book Teaches How to ‘Model the World We Desire’

Reproductive justice founder Loretta Ross has a groundbreaking new book: Calling In: How to Start Making Change with Those You’d Rather Cancel. Ross draws on over 40 years of experience as a feminist activist to offer hope and guidance for how we can learn to communicate and work together across our differences of identity, political opinion and priorities. Calling In is part activist memoir, part how-to guide for calling in and part strategic plan for growing the human rights movement.

Beautifully written and engaging, Calling In is a guide to “compassionate politics”—an antidote to infighting and calling out that is weakening the women’s movement and the left today. 

Pa. Court to Hear Arguments *Feb. 5* on State Ban on Medicaid Coverage for Abortion and Equal Rights Amendment

In January 2024, the Pennsylvania Supreme Court ruled that abortion providers can challenge the Pennsylvania’s Medicaid coverage exclusion on abortion for violating the state’s Equal Rights Amendment and Non-Discrimination Clause of the Pennsylvania Constitution.

On Wednesday, Feb. 5, lawyers for Pennsylvania’s freestanding abortion clinics will argue before the Pennsylvania Commonwealth Court that the ban discriminates on the basis of sex in violation of these constitutional provisions.

The case is the first Pennsylvania state court proceeding challenging an abortion restriction since the state Supreme Court restored the Pennsylvania Equal Rights Amendment last year.

Beyond the Bus: Rosa Parks’ History of Fighting Sexual Violence and Systemic Oppression

Rosa Parks is often remembered as the quiet seamstress who ignited the Montgomery Bus Boycott. Yet, her history as an advocate against sexual violence is often overlooked. Parks’ work demonstrates how the fight against sexual violence is inseparably linked to the fight against systemic oppression, particularly racism, sexism, and misogynoir.

Hip-Hop Icon Roxanne Shanté Gets Her Long-Overdue Grammy Moment

Roxanne Shanté made history once as the first solo female MC in hip-hop, and now she has made history again. On Feb. 1, 2025, the Recording Academy honored her with the Grammy Lifetime Achievement Award, making her the first solo female rapper to receive this recognition. She received the award at the Special Merit Awards Ceremony in Los Angeles, just one day before the official Grammy Awards.

As she reflected on receiving one of the most prestigious honors in music, Shanté opened up about her career, her impact and her ongoing mission to support at-risk youth in this exclusive interview.

Research Supports New Medication Abortion Regime—But Some Fear Political Risks

Gynuity Health Projects has published new research in the New England Journal of Medicine suggesting that a double dose of ulipristal acetate (UPA), sold as an emergency contraceptive under the brand name Ella, taken in combination with the ulcer medication misoprostol, is an effective and acceptable medication abortion regimen with no reported serious adverse events. 

The current recognized clinical standard for first-trimester outpatient abortion is mifepristone and misoprostol, but mifepristone is tightly restricted by the FDA. Ulipristal acetate, on the other hand, currently has no such restrictions.

Some have expressed concern that this research could endanger access to Ella in the United States, and potentially also endanger the FDA-approved over-the-counter emergency contraception Plan B, made from the synthetic hormone levonorgestrel.